For the past 6 months or so, we have all been working under exceptional circumstances and in very different ways. In terms of technology and diabetes. We know there have been moves towards virtual working to different degrees in different places. In particular, we are aware that access to diabetes technologies may have been affected by  the changes in working practices across the country.

ABCD welcomes the publication of the final GIRFT report for Diabetes, which was released on world Diabetes Day. ABCD has been fully supportive of the primary aims of the GIRFT workstream, namely to improve quality of diabetes care in hospitals, and reducing unwanted variations in clinical services and practices. For the first time, the report focussed on three main areas of care: type 1 diabetes care including transition from paediatric to adult care, in-patient diabetes services, and diabetes foot care services.

The British Journal of Diabetes, in conjunction with the Association of British Clinical Diabetologists (ABCD) and the Young Diabetologist and Endocrinologist Forum (YDEF) are pleased to announce the launch of our inaugural quality improvement in diabetes award programme.

We are well into the undesirable 2nd wave of COVID-19 and hospitals are filling up with increasing numbers of patients require hospital services. Clearly, at times like this it is important that Diabetes and Endocrine teams maintain essential In-patient and Outpatient Diabetes and Endocrine services, geared towards supporting patients and avoiding further hospital admissions. The document from SfE is a good guide for the teams to follow.

This is the final ABCD webinar in a series of four.

New education platform focuses on diabetes technology training, data management and remote patient monitoring (RPM)

NICE approve Saxenda injections (GLP-1 therapy) for people with pre-diabetes who have BMI of at least 35 kg/m² and high cardiovascular risk. Further details outlined on NICE website:

https://www.nice.org.uk/news/article/nice-recommends-new-treatment-option-for-adults-with-obesity-and-non-diabetic-hyperglycaemia-who-have-a-high-risk-of-cardiovascular-disease

We provide a range of education to people with diabetes to help them make the best use of diabetes technology.

We offer a range of resources for healthcare professionals, including Academy™ - the educational platform for diabetes technology and a series of educational videos featuring experts in the field.